Skip to main content
Top
Published in: Multidisciplinary Respiratory Medicine 1/2015

Open Access 01-12-2016 | Original research article

Bibliometric analysis of worldwide publications on multi-, extensively, and totally drug – resistant tuberculosis (2006–2015)

Authors: Waleed M. Sweileh, Adham S. AbuTaha, Ansam F. Sawalha, Suleiman Al-Khalil, Samah W. Al-Jabi, Sa’ed H. Zyoud

Published in: Multidisciplinary Respiratory Medicine | Issue 1/2015

Login to get access

Abstract

Background

The year 2015 marked the end of United Nations Millennium Development Goals which was aimed at halting and reversing worldwide tuberculosis (TB). The emergence of drug resistance is a major challenge for worldwide TB control. The aim of this study was to give a bibliometric overview of publications on multi-, extensively, and totally drug-resistant TB.

Methods

Scopus database was used to retrieve articles on multidrug resistant (MDR), extensively drug-resistant (XDR), and totally drug-resistant (TDR) tuberculosis for the study period (2006–2015). The number of publications, top productive countries and institutions, citation analysis, co-authorships, international collaboration, active authors, and active journals were retrieved and analyzed.

Results

A total of 2260 journal articles were retrieved. The mean ± SD citations per article was 7.04 ± 16.0. The h-index of retrieved data was 76. The number of publications showed a three – fold increase over the study period compared with less than two – fold increase in tuberculosis research during the same study period. Stratified by number of publications, the United States of America ranked first while Switzerland ranked first in productivity per 100 million people, and South Africa ranked first in productivity stratified per one trillion Gross Domestic Product. Three of the High Burden Countries (HBC) MDR-TB (India, China, and South Africa) were present in top productive countries. High percentage of international collaboration was seen among most HBC MDR-TB. Except for Plos One journal, most active journals in publishing articles on MDR, XDR, TDR-TB were in infection – related fields and in general medicine. Top 20 cited articles were published in prestigious journal such as Lancet and New England Journal of Medicine. The themes in top 20 cited articles were diverse, ranging from molecular biology, diagnostic tools, co-infection with HIV, and results of new anti-TB drugs.

Conclusion

Publications on MDR, XDR and TDR – TB are increasing in the past decade. International collaboration was common. Many low resourced African and Asian countries will benefit from research leading to new diagnostic and screening technology of TB. The exchange of expertise, ideas and technology is of paramount importance in this field.
Literature
1.
go back to reference Glaziou P, Sismanidis C, Floyd K, Raviglione M. Global epidemiology of tuberculosis. Cold Spring Harb Perspect Med. 2014;5(2):a017798.CrossRefPubMed Glaziou P, Sismanidis C, Floyd K, Raviglione M. Global epidemiology of tuberculosis. Cold Spring Harb Perspect Med. 2014;5(2):a017798.CrossRefPubMed
7.
go back to reference Velayati AA, Masjedi MR, Farnia P, Tabarsi P, Ghanavi J, Ziazarifi AH, et al. Emergence of new forms of totally drug-resistant tuberculosis bacilli: Super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest. 2009;136(2):420–5.CrossRefPubMed Velayati AA, Masjedi MR, Farnia P, Tabarsi P, Ghanavi J, Ziazarifi AH, et al. Emergence of new forms of totally drug-resistant tuberculosis bacilli: Super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest. 2009;136(2):420–5.CrossRefPubMed
9.
go back to reference Velayati AA, Farnia P, Masjedi MR. The totally drug resistant tuberculosis (TDR-TB). Int J Clin Exp Med. 2013;6(4):307–9.PubMedPubMedCentral Velayati AA, Farnia P, Masjedi MR. The totally drug resistant tuberculosis (TDR-TB). Int J Clin Exp Med. 2013;6(4):307–9.PubMedPubMedCentral
10.
go back to reference Migliori G, De Iaco G, Besozzi G, Centis R, Cirillo DM. First tuberculosis cases in Italy resistant to all tested drugs. Euro Surveill. 2007;12(5):E070517.PubMed Migliori G, De Iaco G, Besozzi G, Centis R, Cirillo DM. First tuberculosis cases in Italy resistant to all tested drugs. Euro Surveill. 2007;12(5):E070517.PubMed
11.
go back to reference Organization, W.H. Use of high burden country lists for TB by WHO in the post-2015 era. Geneva: WHO; 2015. Organization, W.H. Use of high burden country lists for TB by WHO in the post-2015 era. Geneva: WHO; 2015.
12.
go back to reference Matteelli A, Migliori GB, Cirillo D, Centis R, Girard E, Raviglion M. Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control. Expert Rev Anti Infect Ther. 2007;5(5):857–71.CrossRefPubMed Matteelli A, Migliori GB, Cirillo D, Centis R, Girard E, Raviglion M. Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control. Expert Rev Anti Infect Ther. 2007;5(5):857–71.CrossRefPubMed
13.
go back to reference Ramos JM, Padilla S, Masiá M, Gutiérrez F. A bibliometric analysis of tuberculosis research indexed in PubMed, 1997–2006. Int J Tuberc Lung Dis. 2008;12(12):1461–8.PubMed Ramos JM, Padilla S, Masiá M, Gutiérrez F. A bibliometric analysis of tuberculosis research indexed in PubMed, 1997–2006. Int J Tuberc Lung Dis. 2008;12(12):1461–8.PubMed
14.
go back to reference Arunachalam S, Gunasekaran S. Tuberculosis research in India and China: From bibliometrics to research policy. Curr Sci. 2002;82(8):933–47. Arunachalam S, Gunasekaran S. Tuberculosis research in India and China: From bibliometrics to research policy. Curr Sci. 2002;82(8):933–47.
15.
go back to reference Gupta B, Bala A. Mapping of tuberculosis research in India: a scientometric analysis of publications output during 1998–2009. COLLNET Journal of Scientometrics and Information management. 2011;5(1):33–51.CrossRef Gupta B, Bala A. Mapping of tuberculosis research in India: a scientometric analysis of publications output during 1998–2009. COLLNET Journal of Scientometrics and Information management. 2011;5(1):33–51.CrossRef
16.
go back to reference Jeyshankar, R. and P. Ganesan, Research Output of Scientist of Tuberculosis Research Centre (TRC), Chennai, Tamil Nadu: A Scientometric Study. Indian J Inf Sources Serv (IJISS). 2011;1(2). Jeyshankar, R. and P. Ganesan, Research Output of Scientist of Tuberculosis Research Centre (TRC), Chennai, Tamil Nadu: A Scientometric Study. Indian J Inf Sources Serv (IJISS). 2011;1(2).
17.
go back to reference Mori T. Trends of tuberculosis researches in Japan and the roles of Kekkaku. Kekkaku. 2009;84(7):519–22.PubMed Mori T. Trends of tuberculosis researches in Japan and the roles of Kekkaku. Kekkaku. 2009;84(7):519–22.PubMed
18.
go back to reference Thompson DF, Walker CK. A descriptive and historical review of bibliometrics with applications to medical sciences. Pharmacotherapy. 2015;35(6):551–9.CrossRefPubMed Thompson DF, Walker CK. A descriptive and historical review of bibliometrics with applications to medical sciences. Pharmacotherapy. 2015;35(6):551–9.CrossRefPubMed
19.
go back to reference Sweileh WM, Zyoud SH, Al-Jabi SW, Sawalha AF. Assessing urology and nephrology research activity in Arab countries using ISI web of science bibliometric database. BMC Res Notes. 2014;7(1):258.CrossRefPubMedPubMedCentral Sweileh WM, Zyoud SH, Al-Jabi SW, Sawalha AF. Assessing urology and nephrology research activity in Arab countries using ISI web of science bibliometric database. BMC Res Notes. 2014;7(1):258.CrossRefPubMedPubMedCentral
20.
go back to reference Zyoud SH, Al-Jabi SW, Sweileh WM, Waring WS. Scientific research related to calcium channel blockers poisoning: Bibliometric analysis in Scopus, 1968–2012. Hum Exp Toxicol. 2015;34(11):1162–70.CrossRefPubMed Zyoud SH, Al-Jabi SW, Sweileh WM, Waring WS. Scientific research related to calcium channel blockers poisoning: Bibliometric analysis in Scopus, 1968–2012. Hum Exp Toxicol. 2015;34(11):1162–70.CrossRefPubMed
21.
go back to reference Sweileh WM, Shraim NY, Al-Jabi SW, Sawalha AF, Rahhal B, Khayyat RA, et al. Assessing worldwide research activity on probiotics in pediatrics using Scopus database: 1994–2014. World Allergy Organ J. 2016;9:25.CrossRefPubMedPubMedCentral Sweileh WM, Shraim NY, Al-Jabi SW, Sawalha AF, Rahhal B, Khayyat RA, et al. Assessing worldwide research activity on probiotics in pediatrics using Scopus database: 1994–2014. World Allergy Organ J. 2016;9:25.CrossRefPubMedPubMedCentral
22.
23.
go back to reference Sweileh WM, Zyoud SH, Al-Jabi SW, Sawalha AF. Contribution of Arab countries to breast cancer research: comparison with non-Arab Middle Eastern countries. BMC Womens Health. 2015;15:25.CrossRefPubMedPubMedCentral Sweileh WM, Zyoud SH, Al-Jabi SW, Sawalha AF. Contribution of Arab countries to breast cancer research: comparison with non-Arab Middle Eastern countries. BMC Womens Health. 2015;15:25.CrossRefPubMedPubMedCentral
24.
go back to reference Zyoud SH, Al-Jabi SW, Sweileh WM. Scientific publications from Arab world in leading journals of Integrative and Complementary Medicine: a bibliometric analysis. BMC Complement Altern Med. 2015;15:308.CrossRefPubMedPubMedCentral Zyoud SH, Al-Jabi SW, Sweileh WM. Scientific publications from Arab world in leading journals of Integrative and Complementary Medicine: a bibliometric analysis. BMC Complement Altern Med. 2015;15:308.CrossRefPubMedPubMedCentral
25.
go back to reference Zyoud SH, Al-Jabi SW, Sweileh WM, Al-Khalil S, Alqub M, Awang R. Global methaemoglobinaemia research output (1940–2013): a bibliometric analysis. Springerplus. 2015;4:626.CrossRefPubMedPubMedCentral Zyoud SH, Al-Jabi SW, Sweileh WM, Al-Khalil S, Alqub M, Awang R. Global methaemoglobinaemia research output (1940–2013): a bibliometric analysis. Springerplus. 2015;4:626.CrossRefPubMedPubMedCentral
26.
go back to reference Zyoud SH, Al-Jabi SW, Sweileh WM, Al-Khalil S, Zyoud SH, Sawalha AF, et al. The Arab world’s contribution to solid waste literature: a bibliometric analysis. J Occup Med Toxicol. 2015;10:35.CrossRefPubMedPubMedCentral Zyoud SH, Al-Jabi SW, Sweileh WM, Al-Khalil S, Zyoud SH, Sawalha AF, et al. The Arab world’s contribution to solid waste literature: a bibliometric analysis. J Occup Med Toxicol. 2015;10:35.CrossRefPubMedPubMedCentral
27.
go back to reference Zyoud SH, Al-Jabi SW, Sweileh WM, Awang R, Waring WS. Bibliometric profile of the global scientific research on methanol poisoning (1902–2012). J Occup Med Toxicol. 2015;10:17.CrossRefPubMedPubMedCentral Zyoud SH, Al-Jabi SW, Sweileh WM, Awang R, Waring WS. Bibliometric profile of the global scientific research on methanol poisoning (1902–2012). J Occup Med Toxicol. 2015;10:17.CrossRefPubMedPubMedCentral
28.
go back to reference Zyoud SH, Zyoud SH, Al-Jabi SW, Sweileh WM, Awang R. Contribution of Arab countries to pharmaceutical wastewater literature: a bibliometric and comparative analysis of research output. Ann Occup Environ Med. 2016;28:28.CrossRefPubMedPubMedCentral Zyoud SH, Zyoud SH, Al-Jabi SW, Sweileh WM, Awang R. Contribution of Arab countries to pharmaceutical wastewater literature: a bibliometric and comparative analysis of research output. Ann Occup Environ Med. 2016;28:28.CrossRefPubMedPubMedCentral
29.
go back to reference Bakkalbasi N, Bauer K, Glover J, Wang L. Three options for citation tracking: Google Scholar, Scopus and Web of Science. Biomed Digit Libr. 2006;29(3):7. Bakkalbasi N, Bauer K, Glover J, Wang L. Three options for citation tracking: Google Scholar, Scopus and Web of Science. Biomed Digit Libr. 2006;29(3):7.
30.
go back to reference Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses. FASEB J. 2008;22(2):338–42.CrossRefPubMed Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses. FASEB J. 2008;22(2):338–42.CrossRefPubMed
31.
go back to reference Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One. 2009;4(9):e6914.CrossRefPubMedPubMedCentral Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One. 2009;4(9):e6914.CrossRefPubMedPubMedCentral
33.
go back to reference van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523–38.CrossRefPubMed van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523–38.CrossRefPubMed
34.
go back to reference Zemlyanaya N, et al. Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia). Eur Respir J. 2015;46 Suppl 59:PA2703.CrossRef Zemlyanaya N, et al. Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia). Eur Respir J. 2015;46 Suppl 59:PA2703.CrossRef
35.
go back to reference Chung-Delgado K, Guillen-Bravo S, Revilla-Montag A, Bernabe-Ortiz A. Mortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and associated factors. PLoS One. 2015;10(3):e0119332.CrossRefPubMedPubMedCentral Chung-Delgado K, Guillen-Bravo S, Revilla-Montag A, Bernabe-Ortiz A. Mortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and associated factors. PLoS One. 2015;10(3):e0119332.CrossRefPubMedPubMedCentral
36.
go back to reference Calver AD, Falmer AA, Murray M, Strauss OJ, Streicher EM, et al. Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa. Emerg Infect Dis. 2010;16(2):264–71.CrossRefPubMed Calver AD, Falmer AA, Murray M, Strauss OJ, Streicher EM, et al. Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa. Emerg Infect Dis. 2010;16(2):264–71.CrossRefPubMed
37.
go back to reference Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366(23):2161–70.CrossRefPubMed Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366(23):2161–70.CrossRefPubMed
38.
go back to reference Thomas A, Joseph P, Nair D, Rao DV, Rekha VV, Selvakumar N, et al. Extensively drug-resistant tuberculosis: experience at the Tuberculosis Research Centre, Chennai, India. Int J Tuberc Lung Dis. 2011;15(10):1323–5. Thomas A, Joseph P, Nair D, Rao DV, Rekha VV, Selvakumar N, et al. Extensively drug-resistant tuberculosis: experience at the Tuberculosis Research Centre, Chennai, India. Int J Tuberc Lung Dis. 2011;15(10):1323–5.
39.
go back to reference Streicher EM, Müller B, Chihota V, Mlambo C, Tait M, Pillay M, et al. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa. Infect Genet Evol. 2012;12(4):686–94.CrossRefPubMed Streicher EM, Müller B, Chihota V, Mlambo C, Tait M, Pillay M, et al. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa. Infect Genet Evol. 2012;12(4):686–94.CrossRefPubMed
40.
go back to reference Chihota VN, Müller B, Mlambo CK, Pillay M, Tait M, Streicher EM, et al. Population structure of multi- and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa. J Clin Microbiol. 2012;50(3):995–1002.CrossRefPubMedPubMedCentral Chihota VN, Müller B, Mlambo CK, Pillay M, Tait M, Streicher EM, et al. Population structure of multi- and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa. J Clin Microbiol. 2012;50(3):995–1002.CrossRefPubMedPubMedCentral
41.
go back to reference Schluger NW, El-Bassel N, Hermosilla S, Terlikbayeva A, Darisheva M, Aifah A, et al. Tuberculosis, drug use and HIV infection in Central Asia: an urgent need for attention. Drug Alcohol Depend. 2013;132:S32–6.CrossRefPubMed Schluger NW, El-Bassel N, Hermosilla S, Terlikbayeva A, Darisheva M, Aifah A, et al. Tuberculosis, drug use and HIV infection in Central Asia: an urgent need for attention. Drug Alcohol Depend. 2013;132:S32–6.CrossRefPubMed
43.
44.
go back to reference Malmborg R, Mann G, Thomson R, Squire SB. Can public-private collaboration promote tuberculosis case detection among the poor and vulnerable? Bull World Health Organ. 2006;84(9):752–8.PubMedPubMedCentral Malmborg R, Mann G, Thomson R, Squire SB. Can public-private collaboration promote tuberculosis case detection among the poor and vulnerable? Bull World Health Organ. 2006;84(9):752–8.PubMedPubMedCentral
45.
go back to reference Zafar Ullah AN, Newell JN, Ahmed JU, Hyder MK, Islam A. Government-NGO collaboration: the case of tuberculosis control in Bangladesh. Health Policy Plan. 2006;21(2):143–55.CrossRefPubMed Zafar Ullah AN, Newell JN, Ahmed JU, Hyder MK, Islam A. Government-NGO collaboration: the case of tuberculosis control in Bangladesh. Health Policy Plan. 2006;21(2):143–55.CrossRefPubMed
46.
go back to reference Schito M, Maeurer M, Kim P, Hanna D, Zumla A. Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done. Clin Infect Dis. 2015;61 Suppl 3:S95–101.CrossRefPubMedCentral Schito M, Maeurer M, Kim P, Hanna D, Zumla A. Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done. Clin Infect Dis. 2015;61 Suppl 3:S95–101.CrossRefPubMedCentral
47.
go back to reference Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis. 2007;196 Suppl 1:S86–107.CrossRefPubMed Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis. 2007;196 Suppl 1:S86–107.CrossRefPubMed
48.
go back to reference Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014;21(1):CD009593. Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014;21(1):CD009593.
49.
go back to reference Vassall A, van Kampen S, Sohn H, Michael JS, John KR, den Boon S, et al. Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med. 2011;8(11):e1001120.CrossRefPubMedPubMedCentral Vassall A, van Kampen S, Sohn H, Michael JS, John KR, den Boon S, et al. Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med. 2011;8(11):e1001120.CrossRefPubMedPubMedCentral
50.
go back to reference Palomino JC, Martin A. TMC207 becomes bedaquiline, a new anti-TB drug. Future Microbiol. 2013;8(9):1071–80. Palomino JC, Martin A. TMC207 becomes bedaquiline, a new anti-TB drug. Future Microbiol. 2013;8(9):1071–80.
51.
go back to reference Maharana RK, AK Das, JK Sahu. Tuberculosis (TB) research in India during 2004–2013: a bibliometric analysis. Libr Philos Pract (e-journal). 2014. Maharana RK, AK Das, JK Sahu. Tuberculosis (TB) research in India during 2004–2013: a bibliometric analysis. Libr Philos Pract (e-journal). 2014.
52.
go back to reference Chen LM, Liu YQ, Shen JN, Peng YL, Xiong TY, Tong X, et al. The 100 top-cited tuberculosis research studies. Int J Tuberc Lung Dis. 2015;19(6):717–22.CrossRefPubMed Chen LM, Liu YQ, Shen JN, Peng YL, Xiong TY, Tong X, et al. The 100 top-cited tuberculosis research studies. Int J Tuberc Lung Dis. 2015;19(6):717–22.CrossRefPubMed
53.
go back to reference Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006;368(9547):1575–80.CrossRefPubMed Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006;368(9547):1575–80.CrossRefPubMed
54.
go back to reference Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med. 2008;177(7):787–92.CrossRefPubMed Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med. 2008;177(7):787–92.CrossRefPubMed
55.
go back to reference Centers for Disease Contr\ol and Prevention (CDC). Emergence of mycobacterium tuberculosis with extensive resistance to second-line drugs - Worldwide, 2000–2004. Morb Mortal Wkly Rep. 2006;55(11):301–5. Centers for Disease Contr\ol and Prevention (CDC). Emergence of mycobacterium tuberculosis with extensive resistance to second-line drugs - Worldwide, 2000–2004. Morb Mortal Wkly Rep. 2006;55(11):301–5.
56.
go back to reference Gler MT, Skripconoka V, Sanchez-Garavito E, Xiao H, Cabrera-Rivero JL, Vargas-Vasquez DE, et al. Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med. 2012;366(23):2151–60.CrossRefPubMed Gler MT, Skripconoka V, Sanchez-Garavito E, Xiao H, Cabrera-Rivero JL, Vargas-Vasquez DE, et al. Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med. 2012;366(23):2151–60.CrossRefPubMed
57.
go back to reference Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: A multicentre implementation study. Lancet. 2011;377(9776):1495–505.CrossRefPubMedPubMedCentral Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: A multicentre implementation study. Lancet. 2011;377(9776):1495–505.CrossRefPubMedPubMedCentral
58.
go back to reference Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med. 2008;359(6):563–74.CrossRefPubMedPubMedCentral Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med. 2008;359(6):563–74.CrossRefPubMedPubMedCentral
59.
go back to reference Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375(9728):1830–43.CrossRefPubMed Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375(9728):1830–43.CrossRefPubMed
60.
go back to reference Raviglione MC, Smith IM. XDR tuberculosis - Implications for Global Public Health. N Engl J Med. 2007;356(7):656–9.CrossRefPubMed Raviglione MC, Smith IM. XDR tuberculosis - Implications for Global Public Health. N Engl J Med. 2007;356(7):656–9.CrossRefPubMed
61.
go back to reference Diacon AH, Pym A, Grobusch M, Patientia R, Rustomjee R, Page-Shipp L, et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med. 2009;360(23):2397–405.CrossRefPubMed Diacon AH, Pym A, Grobusch M, Patientia R, Rustomjee R, Page-Shipp L, et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med. 2009;360(23):2397–405.CrossRefPubMed
62.
go back to reference Udwadia ZF, Amale RA, Ajbani KK, Rodrigues C. Totally drug-resistant tuberculosis in India. Clin Infect Dis. 2012;54(4):579–81.CrossRefPubMed Udwadia ZF, Amale RA, Ajbani KK, Rodrigues C. Totally drug-resistant tuberculosis in India. Clin Infect Dis. 2012;54(4):579–81.CrossRefPubMed
63.
go back to reference Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, Watt CJ, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis. 2006;194(4):479–85.CrossRefPubMed Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, Watt CJ, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis. 2006;194(4):479–85.CrossRefPubMed
64.
go back to reference Caminero JA, Sotgiu G, Zumla A, Migliori GB. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis. 2010;10(9):621–9.CrossRefPubMed Caminero JA, Sotgiu G, Zumla A, Migliori GB. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis. 2010;10(9):621–9.CrossRefPubMed
65.
go back to reference Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Martín-Casabona N, et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis. 2007;13(3):380–7.CrossRefPubMedPubMedCentral Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Martín-Casabona N, et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis. 2007;13(3):380–7.CrossRefPubMedPubMedCentral
66.
go back to reference Hugonnet JE, Tremblay LW, Boshoff HI, Barry CE 3rd, Blanchard JS. Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis. Science. 2009;323(5918):1215–8.CrossRefPubMedPubMedCentral Hugonnet JE, Tremblay LW, Boshoff HI, Barry CE 3rd, Blanchard JS. Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis. Science. 2009;323(5918):1215–8.CrossRefPubMedPubMedCentral
67.
go back to reference Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis. 2009;9(3):153–61.CrossRefPubMed Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis. 2009;9(3):153–61.CrossRefPubMed
68.
go back to reference Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: A meta-analysis. Eur Respir J. 2008;32(5):1165–74.CrossRefPubMed Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: A meta-analysis. Eur Respir J. 2008;32(5):1165–74.CrossRefPubMed
69.
go back to reference Van Deun A, Maug AK, Salim MA, Das PK, Sarker MR, Daru P, et al. Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. Am J Respir Crit Care Med. 2010;182(5):684–92.CrossRefPubMed Van Deun A, Maug AK, Salim MA, Das PK, Sarker MR, Daru P, et al. Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. Am J Respir Crit Care Med. 2010;182(5):684–92.CrossRefPubMed
70.
go back to reference Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, et al. HIV infection and multidrug-resistant tuberculosis - The perfect storm. J Infect Dis. 2007;196 Suppl 1:S86–107. Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, et al. HIV infection and multidrug-resistant tuberculosis - The perfect storm. J Infect Dis. 2007;196 Suppl 1:S86–107.
71.
go back to reference Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One. 2009;4(9):e6914. Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One. 2009;4(9):e6914.
Metadata
Title
Bibliometric analysis of worldwide publications on multi-, extensively, and totally drug – resistant tuberculosis (2006–2015)
Authors
Waleed M. Sweileh
Adham S. AbuTaha
Ansam F. Sawalha
Suleiman Al-Khalil
Samah W. Al-Jabi
Sa’ed H. Zyoud
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Multidisciplinary Respiratory Medicine / Issue 1/2015
Electronic ISSN: 2049-6958
DOI
https://doi.org/10.1186/s40248-016-0081-0

Other articles of this Issue 1/2015

Multidisciplinary Respiratory Medicine 1/2015 Go to the issue